138 related articles for article (PubMed ID: 38347332)
1. Early Onset Intrahepatic Cholangiocarcinoma: Clinical Characteristics, Oncological Outcomes, and Genomic/Transcriptomic Features.
Tsilimigras DI; Han X; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Chaucy F; Koerkamp BG; Endo I; Sasaki K; Aucejo F; Zhang XF; Zhu H; Pawlik TM
Ann Surg Oncol; 2024 May; 31(5):3087-3097. PubMed ID: 38347332
[TBL] [Abstract][Full Text] [Related]
2. Tumor Necrosis Impacts Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma.
Tsilimigras DI; Ejaz A; Cloyd J; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2022 Mar; ():. PubMed ID: 35298762
[TBL] [Abstract][Full Text] [Related]
3. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
[TBL] [Abstract][Full Text] [Related]
4. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract][Full Text] [Related]
5. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
[TBL] [Abstract][Full Text] [Related]
6. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
Zhang XF; Beal EW; Bagante F; Chakedis J; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
Br J Surg; 2018 Jun; 105(7):848-856. PubMed ID: 29193010
[TBL] [Abstract][Full Text] [Related]
7. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
Merath K; Mehta R; Hyer JM; Bagante F; Sahara K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Ejaz A; Pawlik TM
Eur J Surg Oncol; 2019 Jun; 45(6):1084-1091. PubMed ID: 30871884
[TBL] [Abstract][Full Text] [Related]
8. A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis.
Li Q; Zhang J; Chen C; Song T; Qiu Y; Mao X; Wu H; He Y; Cheng Z; Zhai W; Li J; Zhang D; Geng Z; Tang Z
Front Oncol; 2022; 12():896764. PubMed ID: 35814440
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1392-1403. PubMed ID: 36383331
[TBL] [Abstract][Full Text] [Related]
10. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.
Yamashita S; Koay EJ; Passot G; Shroff R; Raghav KP; Conrad C; Chun YS; Aloia TA; Tao R; Kaseb A; Javle M; Crane CH; Vauthey JN
Cancer; 2017 Apr; 123(8):1354-1362. PubMed ID: 27984655
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.
Jing CY; Fu YP; Huang JL; Zhang MX; Yi Y; Gan W; Xu X; Shen HJ; Lin JJ; Zheng SS; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
Oncologist; 2018 Dec; 23(12):1482-1493. PubMed ID: 30257891
[TBL] [Abstract][Full Text] [Related]
12. Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.
Goyal L; Govindan A; Sheth RA; Nardi V; Blaszkowsky LS; Faris JE; Clark JW; Ryan DP; Kwak EL; Allen JN; Murphy JE; Saha SK; Hong TS; Wo JY; Ferrone CR; Tanabe KK; Chong DQ; Deshpande V; Borger DR; Iafrate AJ; Bardeesy N; Zheng H; Zhu AX
Oncologist; 2015 Sep; 20(9):1019-27. PubMed ID: 26245674
[TBL] [Abstract][Full Text] [Related]
13. Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.
Spolverato G; Kim Y; Alexandrescu S; Popescu I; Marques HP; Aldrighetti L; Clark Gamblin T; Miura J; Maithel SK; Squires MH; Pulitano C; Sandroussi C; Mentha G; Bauer TW; Newhook T; Shen F; Poultsides GA; Wallis Marsh J; Pawlik TM
Ann Surg Oncol; 2015 Jul; 22(7):2218-25. PubMed ID: 25354576
[TBL] [Abstract][Full Text] [Related]
14. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
15. A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma.
Fu J; Chen Q; Lai Z; Lin K; Fang G; Ding Z; Gao Y; Zeng Y
BMC Cancer; 2023 Feb; 23(1):188. PubMed ID: 36829168
[TBL] [Abstract][Full Text] [Related]
16. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study.
Zhang Z; Zhou Y; Hu K; Wang D; Wang Z; Huang Y
BMC Cancer; 2020 Mar; 20(1):270. PubMed ID: 32228636
[TBL] [Abstract][Full Text] [Related]
17. Perineural invasion confers poorer clinical outcomes in patients with T1/T2 intrahepatic cholangiocarcinoma: a single center, retrospective cohort study.
Zou M; Sheng J; Ruan M; Zhou W; Ye F; Yang G; Qian Y; Wang J; Wang R; Liu S; Liu H
J Gastrointest Oncol; 2023 Dec; 14(6):2500-2510. PubMed ID: 38196519
[TBL] [Abstract][Full Text] [Related]
18. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
[TBL] [Abstract][Full Text] [Related]
19. Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma.
Xin HY; Sun RQ; Zou JX; Wang PC; Wang JY; Ye YH; Liu KX; Hu ZQ; Zhou ZJ; Fan J; Zhou J; Zhou SL
JAMA Netw Open; 2023 Mar; 6(3):e231476. PubMed ID: 36867406
[TBL] [Abstract][Full Text] [Related]
20. Molecular Detection of
Zou Y; Zhu K; Pang Y; Han J; Zhang X; Jiang Z; Huang Y; Gu W; Ji Y
J Clin Transl Hepatol; 2023 Nov; 11(6):1355-1367. PubMed ID: 37719957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
